1. Home
  2. AADI vs KOSS Comparison

AADI vs KOSS Comparison

Compare AADI & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • KOSS
  • Stock Information
  • Founded
  • AADI 2011
  • KOSS 1953
  • Country
  • AADI United States
  • KOSS United States
  • Employees
  • AADI N/A
  • KOSS N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • KOSS Consumer Electronics/Appliances
  • Sector
  • AADI Health Care
  • KOSS Consumer Staples
  • Exchange
  • AADI Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • AADI 33.6M
  • KOSS 81.3M
  • IPO Year
  • AADI N/A
  • KOSS N/A
  • Fundamental
  • Price
  • AADI $1.57
  • KOSS $9.15
  • Analyst Decision
  • AADI Buy
  • KOSS
  • Analyst Count
  • AADI 2
  • KOSS 0
  • Target Price
  • AADI $5.00
  • KOSS N/A
  • AVG Volume (30 Days)
  • AADI 294.5K
  • KOSS 9.1M
  • Earning Date
  • AADI 08-07-2024
  • KOSS 08-22-2024
  • Dividend Yield
  • AADI N/A
  • KOSS N/A
  • EPS Growth
  • AADI N/A
  • KOSS N/A
  • EPS
  • AADI N/A
  • KOSS N/A
  • Revenue
  • AADI $23,840,000.00
  • KOSS $12,475,699.00
  • Revenue This Year
  • AADI $4.21
  • KOSS N/A
  • Revenue Next Year
  • AADI $8.61
  • KOSS N/A
  • P/E Ratio
  • AADI N/A
  • KOSS N/A
  • Revenue Growth
  • AADI 26.97
  • KOSS N/A
  • 52 Week Low
  • AADI $1.28
  • KOSS $2.27
  • 52 Week High
  • AADI $7.24
  • KOSS $18.73
  • Technical
  • Relative Strength Index (RSI)
  • AADI 50.71
  • KOSS 58.56
  • Support Level
  • AADI $1.46
  • KOSS $8.81
  • Resistance Level
  • AADI $1.69
  • KOSS $11.84
  • Average True Range (ATR)
  • AADI 0.10
  • KOSS 2.79
  • MACD
  • AADI 0.02
  • KOSS -0.06
  • Stochastic Oscillator
  • AADI 67.75
  • KOSS 30.27

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: